Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao Lv

Showing results (321-330 of 422) with videos related to

Pageof 43
Sort By:
International Journal of Cardiology|November 29, 2016
Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertensionXi-Qi Xu, Zi-Chao Lv, Qian-Qian Liu, et al.
Nanoscale|April 22, 2020
Oxygen vacancy-rich amorphous porous NiFe(OH)<sub>x</sub> derived from Ni(OH)<sub>x</sub>/Prussian blue as highly efficient oxygen evolution electrocatalystsShuang Wang, Xingbo Ge, Chao Lv, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 8, 2025
Deep learning model enables the discovery of a novel BET inhibitor YD-851Hongyin Sun, Guoli Xiong, Xin Li, et al.
International Journal of Oncology|August 3, 2022
HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancerYizhou Zhang, Hanrong Li, Chao Lv, et al.
Clinical Lung Cancer|May 12, 2015
A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?Chao Lv, Chao An, Qin Feng, et al.
Acta Pharmaceutica Sinica. B|December 13, 2021
Bruceine D inhibits HIF-1<i>α</i>-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/<i>β</i>-catenin interactionRui Huang, Lijun Zhang, Jinmei Jin, et al.
Cancer Science|September 2, 2016
Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapyPanpan Zhang, Yuanyuan Ma, Chao Lv, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 30, 2025
Nano-Electro-Sampling and Intelligent Analysis System for Real-Time Gene Profiling of Living CellsZhaocun Huang, Feng Liu, Deyuan Zhi, et al.
One Health (Amsterdam, Netherlands)|April 10, 2025
Antimicrobial resistance in <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> at human-animal interfaces on Chongming Island, Shanghai: A One Health perspectiveChao Lv, Jun Leng, Minjian Qian, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 9, 2015
Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancerShiying Zhang, Jianye Li, Gaobiao Zhou, et al.
Pageof 43

Showing results (321-330 of 422) with videos related to

Sort By:
Pageof 43
International Journal of Cardiology|November 29, 2016
Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertensionXi-Qi Xu, Zi-Chao Lv, Qian-Qian Liu, et al.
Nanoscale|April 22, 2020
Oxygen vacancy-rich amorphous porous NiFe(OH)<sub>x</sub> derived from Ni(OH)<sub>x</sub>/Prussian blue as highly efficient oxygen evolution electrocatalystsShuang Wang, Xingbo Ge, Chao Lv, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 8, 2025
Deep learning model enables the discovery of a novel BET inhibitor YD-851Hongyin Sun, Guoli Xiong, Xin Li, et al.
International Journal of Oncology|August 3, 2022
HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancerYizhou Zhang, Hanrong Li, Chao Lv, et al.
Clinical Lung Cancer|May 12, 2015
A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?Chao Lv, Chao An, Qin Feng, et al.
Acta Pharmaceutica Sinica. B|December 13, 2021
Bruceine D inhibits HIF-1<i>α</i>-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/<i>β</i>-catenin interactionRui Huang, Lijun Zhang, Jinmei Jin, et al.
Cancer Science|September 2, 2016
Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapyPanpan Zhang, Yuanyuan Ma, Chao Lv, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 30, 2025
Nano-Electro-Sampling and Intelligent Analysis System for Real-Time Gene Profiling of Living CellsZhaocun Huang, Feng Liu, Deyuan Zhi, et al.
One Health (Amsterdam, Netherlands)|April 10, 2025
Antimicrobial resistance in <i>Escherichia coli</i> and <i>Staphylococcus aureus</i> at human-animal interfaces on Chongming Island, Shanghai: A One Health perspectiveChao Lv, Jun Leng, Minjian Qian, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 9, 2015
Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancerShiying Zhang, Jianye Li, Gaobiao Zhou, et al.
Pageof 43